Mon, Jan 26, 4:10 PM, Zacks
Pfizer's Prevenar 13 Wins CHMP Backing for Expanded Use - Analyst Blog
Pfizer's (PFE) Prevenar 13 is a step closer to EU approval with the CHMP giving a favorable opinion for the prevention of vaccine-type pneumococcal pneumonia in adults aged 18 years and older.
Thu, Jan 22, 2:10 PM, Zacks
Celgene to Use Zymeworks' Azymetric Platform for New Drugs - Analyst Blog
Celgene (CELG) inked a deal with Zymeworks for the research, development and commercialization of bi-specific antibody therapeutics.